![Michael Mulqueen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Mulqueen
No open positions remaining
Profile
Michael Mulqueen worked as the Global Head-Alliance Management at Roche Holding AG from 1992 to 2005.
He then worked as the Vice President-European Operations at Synosia Therapeutics AG, followed by Head-Business Development & Licensing at Silence Therapeutics Plc.
From 2006 to 2011, he served as the Vice President-Business Development at Synosia Therapeutics, Inc. and from 2011 to 2015, he worked as the Vice President-Business Development at Biotie Therapies, Inc. Mr. Mulqueen also has an undergraduate degree from The University of Liverpool.
Former positions of Michael Mulqueen
| Companies | Position | End |
|---|---|---|
Biotie Therapies, Inc. | Corporate Officer/Principal | 2014-12-31 |
Synosia Therapeutics, Inc.
 Synosia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops products for unmet medical needs in psychiatry and neurology | Corporate Officer/Principal | 2010-12-31 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 2004-12-31 |
| SILENCE THERAPEUTICS PLC | Corporate Officer/Principal | - |
Synosia Therapeutics AG
 Synosia Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of psychiatry and neurology diseases | Chief Operating Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
42
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Synosia Therapeutics AG
Synosia Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of psychiatry and neurology diseases | Health Technology |
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synosia Therapeutics, Inc.
Synosia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops products for unmet medical needs in psychiatry and neurology | Health Technology |
Biotie Therapies, Inc. |
- Stock Market
- Insiders
- Michael Mulqueen
